Julie McElrath

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article contains wording that promotes the subject in a subjective manner without imparting real information. Please remove or replace such wording and instead of making proclamations about a subject's importance, use facts and attribution to demonstrate that importance. (August 2018) (Learn how and when to remove this message) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (August 2018) (Learn how and when to remove this message) (Learn how and when to remove this message)

M. Juliana "Julie" McElrath (born January 9, 1951) is a senior vice president and director of the vaccine and infection disease division at Fred Hutchinson Cancer Research Center and the principal investigator of the HIV Vaccine Trials Network Laboratory Center in Seattle, Washington.^[1][2] She is also a professor at the University of Washington.^[3]

McElrath has built and maintains an international HIV vaccine laboratory and has contributed to the fundamental understanding of how HIV-1 – the most common and pathogenic strain of the virus – enters the mucosa to infect people.^[4] Her work centers on developing an HIV vaccine and investigating the complex relationship between HIV and the immune system. She is supported in part by the National Institutes of Health and the Bill & Melinda Gates Foundation.^[1]